Search for Clinical Trial Results

Sponsored By

Myelitis - 237 Studies Found

Status Study
Completed Study Name: Phase III Randomized, Double-Blind, Sham-Controlled Study of Plasma Exchange for Acute Severe Attacks of Inflammatory Demyelinating Disease Refractory to Intravenous Methylprednisolone
Condition:
  • Acute Disseminated Encephalomyelitis
  • Devic's Syndrome
  • Date: 2000-02-24
    Interventions: Procedure: Plasma exchange
Active, not recruiting Study Name: Biobank For MS And Other Demyelinating Diseases
Condition:
  • Multiple Sclerosis
  • Transverse Myelitis
  • Neuromyelitis Optic
    Date: 2007-03-08
Enrolling by invitation Study Name: Safety and Immunogenicity Study of the Venezuelan Equine Encephalomyelitis Vaccine
Condition: Venezuelan Equine Encephalomyelitis
Date: 2007-12-19
Interventions: Biological: VEE TC-83 Subjects will receive a single 0.5 mL dose by subcutaneous route in the upper oute
Suspended Study Name: Safety and Immunogenicity of Venezuelan Equine Encephalomyelitis Vaccine (VEE C-84) as a Booster to VEE TC-83
Condition: Venezuelan Equine Encephalomyelitis
Date: 2007-12-19
Interventions: Biological: VEE C-84 Subjects will receive a 0.5 mL subcutaneous injection in the upper outer aspect of
Not yet recruiting Study Name: Safety and Immunogenicity of Venezuelan Equine Encephalomyelitis Vaccine in Healthy Adults
Condition: Venezuelan Equine Encephalomyelitis Virus Disease
Date: 2017-02-09
Interventions: Biological: VEE Vaccine 0.5 mL of VEE vaccine administered subcutaneously in the upper outer aspect of t
Recruiting Study Name: Oral Melatonin Plus Zinc Supplementation in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (CFS/ME)
Condition:
  • Fatigue Syndrome, Chronic
  • Myalgic Encephalomyelitis

Date: 2016-12-19
Interventions:
  • Dietary Supplement: melatonin plus zinc

Completed Study Name: The Study of the Safety and Efficacy of Ampligen in Chronic Fatigue Syndrome
Condition:
  • Chronic Fatigue Syndrome
  • Myalgic Encephalomyelitis

Date: 2005-09-16
Interventions: Drug: Ampligen
Terminated Study Name: Tumor Necrosis Factor-alpha Inhibition Using Etanercept in Chronic Fatigue Syndrome
Condition:
  • Chronic Fatigue Syndrome
  • Myalgic Encephalomyelitis

Date: 2012-11-08
Interventions: Drug: Etanercept Weekly subcutaneous injections of Etanercept 50 mg, for up to 12 months.
Recruiting Study Name: Reducing Orthostatic Intolerance With Oral Rehydration in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Patients
Condition:
  • Chronic Fatigue Syndrome
  • Myalgic Encephalomyelitis
  • Date: 2016-07-29
    Interventions:
    • Drug: Normal Saline 1 liter of
Recruiting Study Name: Myalgic Encephalomyelitis Chronic Fatigue at the National Institutes of Health
Condition: Chronic Fatigue Syndrome
Date: 2016-01-29
Next >>>